Modern Healthcare News
 
RSS feed

Pharmaceuticals news and information

Information
Clinical trials may be compromised by online patient chatter
By Wall Street Journal | July 30, 2014
Are patients jeopardizing clinical trials by discussing them on social media? There is growing fear in the medical community and the pharmaceutical industry that an increasing number of people who participate in clinical trials may indeed compromise research by chatting about treatments, side...
FULL STORY »
 

News
Hospira earnings double on strong sales of injectable drugs
By Bob Herman | July 30, 2014 | Basic Web Basic Web Subscription Details
Pharmaceutical and medical-device maker Hospira saw its earnings soar in the second quarter of 2014, thanks mostly to large sales of drugs that have been in short supply.
FULL STORY »
 

Vital Signs
Sovaldi likely to cost Medicare billions
By Virgil Dickson | July 29, 2014
The rising cost of hepatitis C drugs like Sovaldi and Olysio will increase Medicare Part D spending by $2.9 billion to $5.8 billion next year and could drive up premiums as much as 8.6%, according to a new report by the actuarial firm Milliman.
FULL STORY »
 

Information
Merck 2Q profit more than doubles
By Associated Press | July 29, 2014
A big one-time gain and a tax benefit helped drugmaker Merck & Co. more than double its second-quarter profit, improve its profit forecast and top analysts' expectations.
FULL STORY »
 

Magazine
HHS reissues disputed 340B policy on orphan-drug discounts
By Jaimy Lee | July 26, 2014 | Print Magazine Print Magazine Subscription Details
HHS has issued an interpretive rule requiring drug companies to provide discounts on orphan drugs sold through the federal 340B drug discount program, just months after a federal judge struck down its previous version of the rule.
FULL STORY »
 


Advertisement | View Media Kit

Magazine
Sovaldi fuels earnings jump for Gilead
By Virgil Dickson | July 26, 2014 | Print Magazine Print Magazine Subscription Details
Gilead Sciences' second-quarter earnings blew through year-ago levels, thanks in part to its blockbuster, controversial hepatitis C drug Sovaldi.
FULL STORY »
 

Information
FDA approves new painkiller from OxyContin maker
By Associated Press | July 24, 2014
The Food and Drug Administration has approved a new combination pain pill from the maker of OxyContin that is designed to discourage abuse by painkiller addicts.
FULL STORY »
 

News
Gilead reports massive Q2 earnings jump thanks to Sovaldi
By Virgil Dickson | July 23, 2014 | Basic Web Basic Web Subscription Details
Gilead Science's second-quarter earnings blew through year-ago levels, thanks in part to its blockbuster, and controversial, hepatitis C drug Sovaldi.
FULL STORY »
 

Information
HIV pills show more promise to prevent infection
By Associated Press | July 22, 2014
There is more good news about HIV treatment pills used to prevent infection in people at high risk of getting the AIDS virus: Follow-up from a landmark study that proved the drug works now shows that it does not encourage risky sex and is effective even if people skip some doses.
FULL STORY »
 

News
HHS reissues disputed 340B policy on orphan-drug discounts
By Jaimy Lee | July 21, 2014 | Basic Web Basic Web Subscription Details
HHS issued an interpretive rule that requires drug companies to provide discounts on orphan drugs sold through a federal program just months after a judge struck down the government's previous version of the rule.
FULL STORY »
 

Search ModernHealthcare.com:


 

Switch to the new Modern Healthcare Daily News app

For the best experience of ModernHealthcare.com on your iPad, switch to the new Modern Healthcare app — it's optimized for your device but there is no need to download.